Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia

NCT00615784 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
24
Enrollment
OTHER
Sponsor class

Stopped Study terminated. Eisai's Targretin acquired by another pharmaceutical company.

Conditions

Interventions

Sponsor

Abramson Cancer Center at Penn Medicine